ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

ChrysCapital acquires controlling 70.68% stake in Novartis' India listed unit in first majority pharma investment
ChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical landscape. Following this acquisition, the company is set to unveil a fresh name and corporate identity. Vikas Gupta
Announcement as on 30 July 2026

Novartis India launches Pluvicto for prostate cancer treatment
Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision radiotherapy precisely targets cancer cells, offering a new treatment approach for metastatic prostate cancer. The t
Announcement as on 15 June 2026

India needs to remain attractive for innovation-led investment: Judith Love, Novartis
With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The company underscores the importance of collaboration to tackle obstacles like high costs and inadequate infrastructure.
Announcement as on 12 June 2026

Novartis expands India role in global drug development
Novartis is focusing on innovative medicines in India. The company is expanding its role in global drug development. Early-stage research is now happening in India. Novartis plans to launch more new medicines soon. This strategy reinforces its commitment t
Announcement as on 11 May 2026

Gainers & Losers: Novartis India and GMDC among 6 stocks in focus on Friday. Here’s why
Novartis India and GMDC led market action on Friday as broader indices recovered, while select stocks saw sharp gains and profit booking.
Announcement as on 20 February 2026

Announcements by Novartis first page | Next page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 1590.17
  • 12Day Average: 1595.63
  • 20Day Average: 1615.65
  • 50Day Average: 1503.35
  • 100Day Average: 1302.56
  • 150Day Average: 1150.29
  • 200Day Average: 1066.95

500672 Indicators & signals

Indicator MACD (12,26,9)

1594.58, 1574.65, 34.04
Indicator MACD is in positive zone

Indicator ADX (14)

1.69, 20.72, 20.04
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 59
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Thu Aug 2026 1551.10 1541.30 to 1599.60 -2.73% 0.7 times
12 Wed Aug 2026 1594.65 1585.50 to 1630.00 0.36% 0.45 times
11 Tue Aug 2026 1588.90 1574.00 to 1613.10 -1.08% 0.38 times
10 Mon Aug 2026 1606.30 1602.20 to 1621.70 -0.22% 0.46 times
07 Fri Aug 2026 1609.90 1560.00 to 1622.90 0.4% 0.71 times
06 Thu Aug 2026 1603.55 1559.00 to 1660.00 -1.79% 0.98 times
05 Wed Aug 2026 1632.80 1614.00 to 1642.95 0.72% 0.45 times
04 Tue Aug 2026 1621.20 1609.00 to 1657.50 -0.31% 0.41 times
03 Mon Aug 2026 1626.25 1525.70 to 1650.00 5.31% 2.13 times
31 Fri Jul 2026 1544.30 1525.70 to 1600.00 -1.82% 2.6 times
30 Thu Jul 2026 1572.85 1570.00 to 1648.00 -1.44% 1.43 times
29 Wed Jul 2026 1595.75 1590.00 to 1623.95 1.07% 1.49 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top